Instituto De Hematologia E Hemoterapia De Sergipe

What Instituto De Hematologia E Hemoterapia De Sergipe does

Instituto De Hematologia E Hemoterapia De Sergipe (IHHS) is a privately held blood bank and hemotherapy services provider founded in 2009 in Aracaju, Sergipe, Brazil. The organization operates as a regional center of scale with 16 employees, 5 transfusion agency locations, and one main facility, serving 21 hospitals and clinics across both the public (SUS) and private (convênio) healthcare networks. Annual throughput exceeds 17,000 donors, 12,000 patients, and 18,000 transfusions, with a 54% donor loyalty rate and 37-minute average donor service time.

The service portfolio spans the full hemotherapy value chain: voluntary, directed, and autologous blood donation; blood component separation (concentrated red blood cells); outpatient transfusion in 8 reclining chairs; therapeutic phlebotomy; intravenous iron infusion (Noripurum and Ferinject); and therapeutic plasmapheresis conducted per American Society for Apheresis (ASFA) protocols with apheresis technology and a multidisciplinary specialist team. The organization also provides pre-operative autotransfusion blood collection for surgical patients at partner institutions. Technology is anchored in clinical protocols and physical infrastructure rather than software platforms, with no AI/ML capabilities disclosed.

Revenue is generated through professional service fees for hemotherapy procedures reimbursed via SUS contracts, convênio health insurance partnerships, and direct private-pay patient billing. Distribution is entirely direct, through the main Aracaju facility and 5 transfusion agency locations across Sergipe. IHHS holds the distinction of being the first private blood bank in Brazil to achieve ACSA International Accreditation at the Excellent (maximum) level, and in 2024 became the first private blood bank qualified to supply human plasma to Hemobrás under Ministry of Health authorization. Additional certifications include ONA III, COFEN quality seal, and Controlab.

Name

Instituto De Hematologia E Hemoterapia De Sergipe

Legal name

Instituto de Hematologia e Hemoterapia de Sergipe

Website

https://ihhs.com.br

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

Instituto De Hematologia E Hemoterapia De Sergipe (IHHS) is a private blood bank and hemotherapy services provider in Aracaju, Sergipe, Brazil, offering blood collection, outpatient transfusion, therapeutic phlebotomy, IV iron infusion, and therapeutic plasmapheresis to 21 hospitals and clinics across public and private healthcare networks.

Ownership category

akta.pro rank

Product category

Blood Bank and Hemotherapy Services

NAICS

Blood and Organ Banks (621991), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro industry

PRIMARYHLAFAMAG

Transfusion Medicine & Immunohematology (Blood Bank)

Healthcare & Life Sciences/Healthcare Providers & Systems/Clinical Laboratories

SECONDARYHLAHAAAH

Blood Bank, Transfusion Medicine & Immunohematology

Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics

SECONDARYHLAIAHAH

Plasma Collection & Donor Services (Plasmapheresis Centers)

Healthcare & Life Sciences/Pharmaceuticals/Plasma-Derived Therapies

Keywords

• Blood bank services
• Hemotherapy services
• Blood transfusion services
• Therapeutic plasmapheresis
• Intravenous iron infusion

Headquarters

HQ city

Aracaju

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain

Revenue model

1. Hemotherapy and blood banking services: IHHS operates as a blood bank providing blood collection, component separation, transfusion services, therapeutic phlebotomy, iron infusion, and therapeutic plasmapheresis to both public and private healthcare networks. Revenue is generated through service provision to hospitals, clinics, and individual patients, with partnerships with health insurance providers (convênios).

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

IHHS operates a private blood bank and hemotherapy center providing blood collection (voluntary, directed, and autologus), blood component separation, outpatient transfusions, therapeutic phlebotomy, intravenous iron infusion (Noripurum and Ferinject), and therapeutic plasmapheresis following ASFA protocols. Services are delivered through the main facility in Aracaju and 5 transfusion agencies to 21 hospitals and clinics across the public and private healthcare networks in Sergipe.

Product overview

Instituto de Hematologia e Hemoterapia de Sergipe (IHHS) operates as a blood bank and hematology/hemotherapy services provider, offering a unified portfolio of interconnected services centered on blood collection, component processing, and transfusion medicine. The core offering is blood donation (Doação de Sangue) which feeds into the organization's supply chain. This is complemented by specialized outpatient therapeutic services including Sangria Terapêutica for periodic therapeutic phlebotomy, Infusão Endovenosa de Ferro (Noripurum/Ferinject) for intravenous iron replacement, Plasmaférese Terapêutica following ASFA protocols, and Transfusão Ambulatorial with 8 reclining chairs for outpatient transfusions. The organization also processes blood components (Concentrado de Hemácias) and provides hemovigilance services. The services are delivered through 5 transfusion agencies serving 21 hospitals and clinics across the public and private network.

Differentiator

Problem solved

Functional benefit

Products and services

• Doação de Sangue (Blood Donation) Blood donation service encompassing voluntary, directed, and autologus collections, performed with rigorous technical and sanitary standards to ensure donor safety and comfort. Targets individual voluntary donors aged 16-69 and feeds the institutional blood supply chain for downstream transfusion and component separation services.
• Sangria Terapêutica (Therapeutic Phlebotomy) Ambulatory therapeutic phlebotomy service for patients requiring periodic blood removal under medical prescription, supervised by IHHS medical team with prior hematologist evaluation.
• Infusão Endovenosa de Ferro (Noripurum e Ferinject) Intravenous iron infusion service administering Noripurum (iron hydroxide saccharose), Ferinject (ferric carboxymaltose) and similar medications for patients with iron deficiency requiring parenteral iron replacement.
• Plasmaférese Terapêutica (Therapeutic Plasmapheresis) Therapeutic plasmapheresis procedure following ASFA (American Society for Apheresis) protocols, using state-of-the-art apheresis equipment and a specialized multidisciplinary team to selectively remove pathological components from blood plasma. Indicated for autoimmune diseases, neurological conditions, hematological pathologies, and renal and systemic disorders.
• Transfusão Ambulatorial (Outpatient Transfusion) Outpatient transfusion service with 8 reclining chairs in a safe, air-conditioned, and comfortable environment for clinically stable patients not requiring hospital admission. Also includes pre-operative auto-transfusions and blood sample collection for surgical patients at partner institutions.

Quantifiable outcome

• 37-minute average donor service time from registration to post-donation snack
• +2 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core.

• Hemobrás (Empresa Brasileira de Hemoderivados e Biotecnologia)coreStrategic or Co-development PartnerIHHS is the first private blood bank in Brazil to supply human plasma to Hemobrás, pursuant to Ofício nº 318/2024/CGSH/DAET/SAES/MS and authorization 14/2024 from the Ministry of Health. This partnership positions IHHS as a key contributor to Brazil's national blood product manufacturing supply chain.
• 21 hospitals and clinics served (Sérgioipe healthcare network)coreOthersIHHS provides blood products and transfusion services to 21 hospitals and clinics across the public and private healthcare networks in Sergipe, supporting the regional healthcare infrastructure with over 18,000 transfusions per year.
• Health insurance providers (convênios)coreOthersIHHS accepts various health insurance plans (convênios) and provides hemotherapy services to insured patients, as indicated by the document submission requirements for insured patients in service pages.

Scale indicators8 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• Hemepar (Centro de Hematologia e Hemoterapia do Paraná): State blood center of Paraná providing blood collection, component separation, and transfusion services. Comparable to IHHS in regional blood bank operations, hospital network service model, and reliance on SUS-aligned public health reimbursement.
• Fundação Hemocentro de Brasília: Federal District blood center in Brasília providing blood collection, hematology, and hemotherapy services. Comparable to IHHS as a regional hemotherapy center serving both public and private hospital networks with apheresis capabilities.
• Hemorio: State blood center of Rio de Janeiro performing blood collection, component separation, and transfusion medicine services. Directly comparable to IHHS as a regional blood bank serving public and private hospitals with 24-hour operations.
• Fundação Hemominas: Blood center of Minas Gerais offering blood collection, hemotherapy, and hematology services. Directly comparable to IHHS as a regional hemotherapy provider serving multiple hospitals with similar accreditation-driven operating model.
• Fundação Pró-Sangue (Hemocentro de São Paulo): Major public blood bank in São Paulo that collects, processes, and distributes blood products across a hospital network. Comparable to IHHS in core blood-bank operations and transfusion medicine services, though at a much larger public-scale footprint.

Others

• Haemonetics: Provider of blood and plasma component management solutions including apheresis equipment. Comparable to IHHS as a technology counterpart serving the same blood bank and plasma collection workflow that IHHS operates.
• CSL Behring: Global plasma-derived therapies manufacturer that is the international counterpart to Hemobrás. Comparable to IHHS as a downstream customer of plasma fractionation, illustrating the scale of the plasma-supply value chain IHHS has entered into via its Hemobrás contract.
• Terumo BCT: Global manufacturer of apheresis and blood component processing equipment. Comparable to IHHS as the supplier of the apheresis technology IHHS uses for therapeutic plasmapheresis under ASFA protocols.

Broad incumbents

• Hospital Sírio-Libanês: High-end Brazilian hospital providing in-house blood bank, apheresis, and transfusion services. Comparable to IHHS in component-separation and apheresis capabilities, but as part of a broader acute-care hospital portfolio rather than a dedicated blood bank.
• Hospital Israelita Albert Einstein: Premier Brazilian hospital network offering in-house blood bank and transfusion services as part of a broader healthcare portfolio. Comparable to IHHS in transfusion medicine service line but operates as a much larger multi-specialty hospital system.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/123448674503251
• Instagraminstagram.com/ihhs_aracaju_sergipe
• LinkedInlinkedin.com/company/instituto-de-hematologia-e-hemoterapia-de-sergipe

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Instituto De Hematologia E Hemoterapia De Sergipe